Literature DB >> 26350364

Prognostic Impact of Histologic Type in Curatively Resected Stage IV Colorectal Cancer: A Japanese Multicenter Retrospective Study.

Junichi Shibata1, Kazushige Kawai2, Takeshi Nishikawa2, Toshiaki Tanaka2, Junichiro Tanaka2, Tomomichi Kiyomatsu2, Keisuke Hata2, Hiroaki Nozawa2, Shinsuke Kazama2, Hironori Yamaguchi2, Soichiro Ishihara2, Eiji Sunami2, Joji Kitayama2, Kenichi Sugihara3, Toshiaki Watanabe2.   

Abstract

BACKGROUND: This study aimed to clarify differences in prognostic factors, metastatic features, and recurrence rates between histologic types in patients with stage 4 colorectal cancer (CRC) who had undergone curative resection.
METHODS: The data from 1131 patients with stage 4 colorectal cancer from the databases of referral institutions were analyzed. The patients were divided into two groups according to histologic types as follows: patients with poorly differentiated adenocarcinoma, mucinous adenocarcinoma, or signet-ring cell carcinoma (Por/Muc/Sig) and patients with well-differentiated or moderately differentiated adenocarcinoma (Wel/Mod). Differences in clinicopathologic features, relapse-free survival (RFS) rates, and cancer-specific survival (CSS) rates between the groups were evaluated.
RESULTS: Although RFS did not differ between the Por/Muc/Sig and Wel/Mod groups, CSS was significantly shorter in the Por/Muc/Sig group's than in the Wel/Mod group, and survival after recurrence was significantly worse in the Por/Muc/Sig group than in theWel/Mod group. The incidence of peritoneal or local recurrence was significantly higher for the Por/Muc/Sig patients, whereas the resection recurrence rate was 16.4 %. Multivariate analysis suggested that histologic type was an independent prognostic factor for survival after recurrence.
CONCLUSIONS: The patients with Por/Muc/Sig CRC synchronous metastasis had significantly shorter survival times than the patients with other CRC histologies, even if the metastases were curatively resected.

Entities:  

Mesh:

Year:  2015        PMID: 26350364     DOI: 10.1245/s10434-015-4846-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  3 in total

1.  Impact of sex and histology on the therapeutic effects of fluoropyrimidines and oxaliplatin plus bevacizumab for patients with metastatic colorectal cancer in the SOFT trial.

Authors:  Yasuhide Yamada; Kei Muro; Keiichi Takahashi; Hideo Baba; Yoshito Komatsu; Taroh Satoh; Masahiro Goto; Hideyuki Mishima; Masahiko Watanabe; Yuh Sakata; Satoshi Morita; Yasuhiro Shimada; Naruhito Takenaka; Tadashi Hirooka; Kenichi Sugihara
Journal:  Glob Health Med       Date:  2020-08-31

2.  Impact of histological subtype on prognosis in stage IV colorectal cancer: A population-based cohort study.

Authors:  Teppei Miyakawa; Hidetaka Kawamura; Michitaka Honda; Yoshinao Takano; Shunji Kinuta; Takahiro Kamiga; Shigeru Yamazaki; Atsushi Muto; Satoru Shiraso; Naoyuki Yamashita; Toshiyasu Iwao; Koji Kono; Shinichi Konno
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

3.  Application of contrast-enhanced ultrasound in the pathological grading and prognosis prediction of hepatocellular carcinoma.

Authors:  Zhidong Xuan; Na Wu; Chao Li; Yongrong Liu
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.